Bokf, Na Pfizer Inc Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Pfizer Inc stock. As of the latest transaction made, Bokf, Na holds 143,073 shares of PFE stock, worth $3.67 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

143,073

Previous 153,857 7.01%

Holding current value

$3.67 Million

Previous $4.3 Million 3.81%

% of portfolio

0.07%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $298,716 - $338,509	-10,784 Reduced 7.01%	143,073 $4.14 Million
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $1.22 Million - $1.42 Million	-48,114 Reduced 23.82%	153,857 $4.3 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $2.21 Million - $2.54 Million	-85,332 Reduced 29.7%	201,971 $5.6 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $931,064 - $1.21 Million	-35,632 Reduced 11.03%	287,303 $8.27 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $2.1 Million - $2.46 Million	-65,560 Reduced 16.88%	322,935 $10.7 Million
Q2 2023 Aug 21, 2023	SELL	$36.12 - $41.79 $1.09 Million - $1.26 Million	-30,103 Reduced 7.19%	388,495 $14.2 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $8.12 Million - $10.6 Million	-206,256 Reduced 33.01%	418,598 $17.1 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $322,268 - $420,685	-7,719 Reduced 1.22%	624,854 $32 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $670,534 - $818,554	15,323 Added 2.48%	632,573 $27.7 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $305,469 - $362,191	6,565 Added 1.08%	617,250 $32.4 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $3.92 Million - $4.86 Million	85,662 Added 16.32%	610,685 $31.6 Million
Q4 2021 Mar 11, 2022	BUY	$41.32 - $61.25 $838,134 - $1.24 Million	20,284 Added 4.02%	525,023 $31 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $1.35 Million - $1.74 Million	-34,505 Reduced 6.4%	504,739 $21.7 Million
Q1 2021 Apr 21, 2021	SELL	$33.49 - $37.77 $7.48 Million - $8.44 Million	-223,372 Reduced 29.29%	539,244 $19.5 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $2.59 Million - $3.3 Million	-77,505 Reduced 9.23%	762,616 $28.1 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $2.33 Million - $2.74 Million	73,451 Added 9.58%	840,121 $30.8 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $2.08 Million - $2.53 Million	69,135 Added 9.91%	766,670 $25.1 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $164,504 - $235,041	6,086 Added 0.88%	697,535 $22.8 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $2.16 Million - $2.45 Million	65,630 Added 10.49%	691,449 $27.1 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $3.34 Million - $4.33 Million	-102,892 Reduced 14.12%	625,819 $22.5 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $2.23 Million - $2.51 Million	-60,366 Reduced 7.65%	728,711 $31.6 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $576,600 - $633,491	-15,376 Reduced 1.91%	789,077 $33.5 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $7.89 Million - $8.99 Million	205,078 Added 34.22%	804,453 $35.1 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $1.53 Million - $1.86 Million	44,412 Added 8.0%	599,375 $26.4 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $842,111 - $897,775	-25,534 Reduced 4.4%	554,963 $20.1 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $543,746 - $630,820	17,040 Added 3.02%	580,497 $20.6 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $86,908 - $92,212	2,613 Added 0.47%	563,457 $20.4 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $213,900 - $235,635	6,900 Added 1.25%	560,844 $20 Million
Q2 2017 Aug 14, 2017	BUY	N/A	553,944	553,944 $18.6 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account